View the latest company news, press releases, and FDA clearances to see exciting milestones at Acuitive Technologies.
The 2022 Society for Biomaterials, Technology Innovation and Development Award goes to Dr. Guillermo Ameer and the Acuitive Technologies Team
BALTIMORE, MD., May 2022
It all started with a vision by Northwestern's Dr. Guillermo A. Ameer, Daniel Hale Williams Professor of Biomedical Engineering at the McCormick School of Engineering and Surgery at the Feinberg School of Medicine, who has been awarded the 2022 Technology Innovation and Development Award by the Society for Biomaterials. This award recognizes an individual or team's successful application of basic and applied biomaterials research in the development of a novel medical product or technology that significantly benefits the health and well-being of patients.
Biomaterial Technology Moves from Lab Bench to the Orthopedic Market
EVANSTON, IL., December 2021
Northwestern biomedical engineer Guillermo A. Ameer has achieved a rare, major accomplishment: A medical product based on novel biomaterials pioneered in his laboratory will be widely available for use in musculoskeletal surgeries to directly benefit patients. The biomaterial technology, called CITREGEN®, developed by the startup company Acuitive Technologies Inc., is featured in Stryker Corporation’s CITRELOCK®, an innovative device that debuted in September.
Acuitive Technologies Enters Sport Medicine Market - CITRESPLINE™ & CITRELOCK®
ALLENDALE, NJ., March 4th, 2021
Acuitive Technologies Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRESPLINE and CITRELOCK® Ligament Reconstruction Devices using their patented CITREGEN® biomaterial technology, a market disruptive bioresorbable synthetic polymer.
Acuitive Technologies Granted FDA 510(k) Clearance for CITREFIX™ Knotless Suture Anchor
ALLENDALE, NJ., February 11th, 2021
Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITREFIX™ Knotless Suture Anchor System with CITREGEN® material technology, a new generation bioresorbable synthetic polymer.
Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN® CITRELOCK® Tendon Interference Screw System
ALLENDALE, NJ., October 21st, 2020
Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRELOCK Interference Screw System with CITREGEN material technology, a new generation thermoset bioresorbable synthetic polymer now FDA cleared.
Ameer Named to National Academy of Medicine
EVANSTON, IL., October 18th, 2021
Northwestern Engineering’s Guillermo A. Ameer was one of three University faculty elected to the National Academy of Medicine (NAM). Ameer is the Daniel Hale Williams Professor of Biomedical Engineering in the McCormick School of Engineering and a professor of surgery in Northwestern’s Feinberg School of Medicine, and also the founding director of Northwestern’s Center for Advanced Regenerative Engineering. He is director of the recently established Regenerative Engineering Training Program at the McCormick School of Engineering, supported by the National Institutes of Health.
Acuitive Technologies Collaborates with Ireland-Based Research Institute, CÚRAM
Through their collaboration with CÚRAM, Acuitive Technologies Inc. has demonstrated the scientific potential of their paradigm-changing bioactive CITREGEN™ platform technology to expedite tissue healing and mitigate the problems associated with currently marketed biodegradable devices for numerous musculoskeletal applications